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1. Introduction 
Adenosine has been reported to regulate adenylate 
cyclase (ATP pyrophosphate lyase (cyclizing) 
EC 4.6.1 .l .) in various cell types [ 1 - 1 I]. This nucleo- 
side and structural analogues induce cyclic AMP 
(CAMP) accumulation i rat thymocytes [121 and in 
human lymphocytes [13,141. They inhibit cytotoxic 
T lymphocyte-mediated cytolysis by increasing CAMP 
level [15,16]. In [17,18] we showed that the early 
increases in CAMP content induced by 2chloroade- 
nosine (an adenosine de~na~-res~tent analogue) 
in pig lymph node lymphocytes could not be corre- 
lated to similar effects on the adenylate cyclase 
activity of disrupted cell preparations, but rather to 
the competitive inhibition of the low Km CAMP 
phosph~iestera~. This points out the difficulty to 
draw definitive conclusions from experiments carried 
out on intact cells or on homogenates with incomplete 
blockade of phosphodiesterases. In spite of the data 
for mouse thymocytes [191 direct stimulation of 
lymphoc+te adenylate cyclase by adenosine or ana- 
logues has never been clearly established. 
Here we demonstrate that these nucleosides at 
submicromolar concentrations directly stimulate 
adenylate cyclase in cell-free systems from mouse 
thymocytes and, to a lesser extent, of mouse spleno- 
cytes. 
2. Materials and methods 
Creatine phosphate and creatine phosphokinase 
were obtained from Boehringer, 2-chloroadenosine, 
Elsevi~~Nor~~-Hound Biomedical Press 
isoproterenol, prostaglandin El, calf intestinal mucosa 
adenosine deaminase from Sigma, [(Y-~~P]ATP from 
Amersham Radiochemical Centre, c [3H]AMP from 
CEN Saclay. 
Thymus were removed from week 4-5 male Swiss 
mice, the cells were teased apart in Hanks medium, 
filtered through nylon screen and washed twice with 
Hanks medium. Splenocytes were obtained by homo- 
genizing mouse spleens in a glass Potter homogenizer. 
Contaminating erythrocytes were selectively killed by 
0.83% ammo~um chloride. 
The cells were washed with 0.9% NaCl, then resus- 
pended in a hypotonic solution consisting of 10 mM 
Tris-HCl (PH 7.5) (~1 ml/2-3 X 10’ cells) using a 
teflon-glass homogenizer (4 gentle strokes with 
hand), Aggregated material was removed by filtra- 
tion throu~ a very small ayer of glass wool and the 
filtrate immediately used for adenylate cyclase deter- 
minations. 
Determination of intracellular CAMP levels was 
carried out as in [ 181 with a protein binding assay, 
using the Amersham Radiochemical Centre kit, after 
pu~~cation of the cell extracts on Dowex-resin 
columns. 
Adenylate cyclase was determined as in [20] in 
25 mM Tris-HCl (pH 7.5) containing 25 U creatine 
phosphokinase/ml, 15mM creatine phosphate 2.5 mM 
Mg&, 1 mM cAMP,O.S mM fru-3q]ATP(l.5-3 X lo6 
cpm~assay) and in some expe~ments 0.6 U adenosine 
deaminasejml. ATP was pre-purified on Dowex resin 
as in [ 11. The reaction (100 fi) lasted 15 min at 30°C 
and was stopped by adding 150 ~110 mM Tris,HCl 
(pH 7.5) containing 5 mM ATP, 50 PM c [3H]AMP 
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(-20 000 cpm/assay) and by heating the tubes for 
3 min. c[~“P]AMP was purified as in [l] using two 
successive chromato~ap~es onDowex resin and 
alumina columns. 
3. Results 
3.1. Effects of adenosine and Z-c~Z#roade~os~~e on 
CAMP ac~urnula~.~n in mouse thymocytes and 
splenocy tes 
Short incubations (12 min) of mouse thymocytes 
or splenocytes with adenosine or 2chloroadenosine 
induced large increases in their CAMP content (table 
1). The effects were more pronounced for thymo- 
cytes than for splenocyies, and 2-chloroadenosine 
was found much more efficient than adenosine, prob- 
ably because it is resistant to adenosine deaminase. 
Up to 1 S-fold enhancements of CAMP content were 
Table 1 
Effects of adenosine and bchloroadenosine on CAMP 
accumulation in mouse thymocytes and splenocytes 
CAMP content 
(% control) 
1. Thymocytes 
Control 
5 X lo-’ M adenosine 
2 X lo-’ M adenosine 
5 x 1Cr6 M adenosine 
1o-5 M adenosine 
lo-’ M Z-c~oroadeno~ne 
lo-* M Zchloroadenosine 
5 X lob6 M Z-chloroadenosine 
lOOa: 10 
130* 10 
28Oi 30 
6101: 30 
740* 50 
12oi 10 
52Oi 30 
1500 f 200 
2. Splenocytes 
Control 100 c 10 
10-6 M adenosine 150* 20 
10-$ M adenosine 270 f 20 
10+ M adenosine 300* 30 
1o-6 M 2-chloroadenosine 210* 20 
1o-5 M 2-chloroadenosine 800* 50 
After 30 min equilibration at 37’C, 1 ml aliquots of thymocytes 
or splenocytes in Hanks’ medium (15 X lo6 cells/ml) were 
incubated 12 min at 37°C in the presence of indicated 
nucleoside doses. The CAMP contents of the controls were 
7.5 * 2.5 pmol/lO’ thymocytes and 10 f 2 pmol/107 spleno- 
cytes. Results are the mean of 3 separate determinations for 
each assay 
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induced by 5 PM 2-chloroadenosine i  mouse thymo- 
cytes. It is possible that part of these stimulations 
were due to a nucleoside-induced ~hibition of CAMP- 
phosphodiesterases [ 181. The fact that sub-&M doses 
of nucleosides are sufficient o produce significant 
effects is consistent with a direct stimulation of 
adenylate cyclase, reminiscent of the action of hor- 
mones. Moreover, to determine whether adenosine 
must enter the cell to produce its effect, we checked 
for the action of 6.chloropurine riboside, an inhibitor 
of adenosine transport already used in guinea pig 
heart [22]. In our assay conditions 100 PM 6-chloro- 
purine riboside inhibited adenosine transport in 
thymocytes by 9% (see [23] for measurement 
technique} and yet did not antago~ze the stimula- 
tion effect of 2-chloroadenosine (table 2), which 
suggests hat this latter compound acts through 
extracellular receptor sites. However the decisive 
proof of the existence of adenosine receptors coupled 
to adenylate cyclase can only be given by directly 
measuring the adenylate cyclase activities of dis- 
rupted cell preparations. 
3.2. Effects of 2-chloroadenosine on the adenylate 
cyclase activity of mouse thymocytes and 
sp~e~ocytes 
Figure 1 represents he dose-response curve 
relative to the modulation of the adenylate cyclase 
activity of homogenates from mouse thymocytes and 
splenocytes, under experimental conditions where 
CAMP-phosphodiesterases were saturated with 1 mM 
Table 2 
Effects of 6-chloropurine riboside on 2-chloroadenosine 
induced CAMP accumulation in mouse thymocytes 
Treatment of the cells CAMP content 
(pmol~l0’ cells) 
Control 
1 PM 2-chloroadenosine 
100 FM 6-chloropurine riboside 
100 MM 6-chloropurine riboside 
+ 1 PM Zchloroadenosine 
11.6 * 0.7 
37.6 f 3.1 
12.3 * 1.6 
38.7 + 2.9 
After 30 min equilibration at 37OC, thymocytes (1.3 X 10’ 
cells/ml Hanks’ medium) were incubated for 6 min with or 
without 100 PM 6-chloropurine rmoside, then for 12 min 
with or without 1 PM 2-chloroadenosine. Results are the 
mean of 3 separate determinations for each assay 
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Fig. 1. Stimulation f mouse thymocyte and splenocyte 
adenylate cyclase by 2~hlo~adeno~e. The effects of vti- 
ous doses of 2-chloroadenosine were tested on the adenylate 
cyclase activity of freshly prepared homogenates from mouse 
thymocytes (0 - - e) and spbnocytes (W - - n ), as in section 2. 
Each point represents the mean of 3 separate determinations, 
CAMP. The extent of stimulation was much greater 
for thymocytes than for splenocytes, in agreement 
with the determinations of CAMP content of intact 
cells (table 1); the doses of 2-chloroadenosine ces- 
sary for half-maximal stimulation were about 0.55 bM 
and 0.9 PM for thymocytes and splenocytes, respec- 
tively. 
The addition of GTP (<lo0 /.M) in the assay 
medium did not improve the responsiveness of 
adenylate cyclase to 2-chloroadenosine. 
The presence of exogenous adenosine deaminase 
during the preincubation period and during the 
reaction time, as described [4] neither affected the 
basal adenylate cyclase activity nor the 2chloroade. 
nosine-stimulated activity; this means that the contri- 
bution of endogenous adenosine was negligible, prob- 
ably because its concentration ismaintained to a low 
level by endogenous adenosine deaminase activity (and 
perhaps by other enzymatic activities) of the homog- 
enates. This inactivation of adenosine (which is 
expected to be more important in homogenates than 
in intact cells) was confirmed when we tested adeno- 
sine itself on thymocyte adenylate cyclase; the sensi- 
tivity of the enzyme to adenosine was considerably 
reduced as compared to the response to 2&loro- 
adenosine and was shifted towards higher concentra- 
tions. Only adenosine doses at >lO FM induced sig 
nificant stimulations (30% stimulation with 100 PM 
adenosine, table 3). 
The reversal of adenosine or analogue ffects on 
adenylate cyclase by theophylhne has often been 
considered as a criterion for the existence of adeno- 
sine receptors [3,4,9,13,14]; we did find that theo- 
phylline almost completely reversed the 2-chloro- 
adenosine stimulation (table 3). The data presented 
in table 3 also show that classical stimulators of 
adenylate cyclase (prosta~and~ Er, isoproterenol 
and fluoride ions) strongly enhanced this enzyme 
activity in mouse thymocytes (3.1-, 3.9- and S-fold 
stimulation, respectively). The splenocyte adenylate 
cyclase was stimulated by prostaglandin Et (2.4-fold) 
and by fluoride (S-fold). 
4. Discussion 
Adenosine-sensitive adenylate cyclase activities 
have been reported for a certain number of cell types; 
adenosine or structural analogues produced stimula- 
tion in neuroblastoma cells [3,9], striatum [4], human 
glioma cell and fibroblast lines [l], erythrocytes [B], 
adrenal and Ieydig tumor cells [lo], inhibition in 
liver [5 J, in fat cells [7] and thyroid [ Ill, or biphasic 
response in platelets [2,6]. These nucleosides are able 
to increase CAMP accumulation i  mouse cytotoxic T 
lymphocytes [I 5,161, rat thymic lymphocytes [121 
and human peripheral lymphocytes [13,141. However 
direct stimulation of adenylate cyclase by adenosine 
had never been clearly established for a lymphocyte 
cell free system. Among the above mentioned works, 
the most conclusive would be that in [ 141 where 
adenosine doses at lo-’ M were found to enhance 
the CAMP content of human lymphocytes, but their 
lymphocyte preparations from blood were contami- 
97 
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Table 3 
Responses of thymocyte adenylate cyclase to adenosine, 2-chloroadenosine, 
prostaglandin E,, isoproterenol and fluoride. Reversal of f-chloroadenosine 
effect by theophylline 
Effecters Adenylate cyclase 
(% basal activity) 
None lOOi 3 
100 PM adenosine 130+ 8 
5 PM 2-chloroadenosine 195* 2 
100 PM theophylline 87+ 4 
100 PM theophylline 89+ 1 
5 PM 2-chloroadenosine +100 PM theophylline llO+ 8 
5 PM 2chloroadenosine + 200 MM theophylline 103 f 4 
10 MM prostaglandin E, 312 * 11 
20 MM isoproterenol 391+ 31 
10 mM NaF 494 f 30 
Adenylate cyclase of freshly prepared homogenates was determined as in section 
2. The adenosine assays were carried out without exogenous adenosine deaminase. 
The addition of 0.6 U exogenous adenosine deaminasc/ml did not change any of 
the other activities. We have checked that 100 PM 6chloropurine riboaide did not 
affect basal or 2-chloroadenosine-stimulated ad nylate cyclase activity. Results 
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are the mean of 3 separate determinations 
nated with platelets. Zenser claimed to have observed 
direct stimulation of the adenylate cyclase of mouse 
thymocyte homogenates [ 191, but his enzyme deter- 
minations were carried out in the presence of 0.5 mM 
RO-20-1724 which does not completely inhibit the 
CAMP phosphodiesterases [ 181; in our work on pig 
lymph node lymphocytes we demonstrated that when 
CAMP phosphodiesterases were not completely blocked 
or saturated their inhibition by adenosine analogues 
could account for the measured stimulations of CAMP 
production by cell homogenates [ 181. 
These data unambiguously demonstrate that mouse 
thymocyte (and to a lesser extent mouse splenocyte) 
homogenate adenylate cyclase can be directly stimu- 
lated by 2chloroadenosine, under experimental con- 
ditions where CAMP phosphodiesterases were saturated 
with CAMP. The low doses at which stimulation 
occured (half-maximal stimulation of thymocyte ade- 
nylated cyclase with 0.55 PM nucleoside) together 
with the shape of the dose-response curve which is 
similar to those obtained for hormone stimulation, 
ascertain the existence of adenosine receptors coupled 
to adenylate cyclase; our mouse thymocyte system 
fulfils classical criteria for the presence of such recep- 
tors: the 2chloroadenosine action in disrupted cell 
preparations was reversed by theophylline and the 
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nucleosideinduced CAMP accumulation in intact cells 
was not reversed by 6-chloropurine riboside, a potent 
inhibitor of adenosine transport. 
We have no definite explanation for the difference 
of responsiveness between thymocytes and spleno- 
cytes; it is not due to a complete lack of sensitivity 
of B lymphocytes since we verified that splenocytes 
from homozygous (nu/nu) mice displayed the same 
response as those from heterozygous (nu/+) mice. 
Apart from possible differences in maturation or func- 
tions, the observed differences might also be the result 
of variable lability of adenosine receptors or slight 
variations in the methods of cell isolation. Our nega- 
tive results reported for pig lymph node lymphocytes 
[ 181 might have been due to the lability of adenosine 
receptors, as a consequence of the more drastic method 
of tissue homogenization. 
The presence in the membrane of adenosine recep- 
tors coupled to lymphocyte adenylate cyclase confers 
to adenosine a hormone-like role, and strenghtens the 
hypothesis formulated by several authors that CAMP 
(which inhibits many lymphocyte functions [24]) is 
involved in the immunosuppressive action of adeno- 
sine and particularly in the association of severe 
combined immunodeficiency with adenosine dea- 
minase deficiency [ 12-161. One can predict that 
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any mechanism which regulates the level of adenosine 
may influence the intracellular level of CAMP; we 
have obtained evidence for a S’nucleotidase-ade- 
nylate cyclase correlation and tested the hypothesis 
that concanavalin A, which inhibits 5’nucleotidase 
[25,26], might indirectly control CAMP through the 
level of adenosine (in preparation). 
Acknowledgements 
This work received financial support from the 
Centre National de la Recherche Scientitique and the 
Fondation pour la Recherche Medicale Francaise. The 
authors acknowledge skilful technical assistance of 
R. Larguier and N. Bemad. 
References 
[II 
[21 
131 
141 
[51 
[61 
171 
Clark, R. B. and Seney, M. N. (1976) J. Biol. Chem. 
251,4239-4246. 
Haslam, R. J. and Lynham, J. A. (1972) Life Sci. 11, 
1143-1154. 
Penit, J., Cantau, B., Huot, J. and Jard, S. (1977) Proc. 
Natl. Acad. Sci. USA 74, 1575-1579. 
Premont, J., Perez, M. and Bockaert, J. (1977) MoL 
Pharmacol. 13,66 2-670. 
Londos, C. and Preston, M. S. (1977) J. Biol. Chem. 
252,5951-5956. 
Londos, C. and Wolff, J. (1977) Proc. Natl. Acad. Sci. 
USA 74,5482-5486. 
Fain, J. N., Pointer, R. H. and Ward, W. F. (1972) 
J. Biol. Chem. 247,6866-6872. 
[81 
[91 
[LOI 
1111 
1121 
1131 
1141 
[I51 
[I61 
1171 
[La1 
[I91 
1201 
t211 
[221 
~231 
1241 
[251 
1261 
Sevilla, N., Tolkovski, A. M. and Levitski, A. (1977) 
FEBS Lett. 81, 339-341. 
Blume, A. J. and Foster, C. J. (1975) J. Biol. Chem. 
250,5003-5008. 
Wolff, J. and Cook, G. H. (1977) J. Biol. Chem. 252, 
687-693. 
Wolff, J., Londos, C. and Cook, G. H. (1978) Arch. 
Biochem. Biophys. 191,161-168. 
Nordeen, S. K. and Young, D. A. (1977) J. Biol. Chem. 
252,5324-5331. 
Schwartz, A. L., Stern, R. C. and Polmar, S. H. (1978) 
Clin. Immunol. Immunopath. 9,499-500. 
Marone, G., Plaut, M. and Lichtenstein, L. M. (1978) 
J. Immunol. 121,2153-2159. 
Wolberg, G., Zimmerman, T. P., Hiemstra, K., Winston, 
M. and Chu, L. C. (1975) Science 187,957-959. 
Wolberg, G., Zimmerman, T. P., Duncan, G. S., Singer, 
K. H. and Elion, G. B. (1978) Biochem. Pharmacol. 27, 
1487-1495. 
Bonnafous, J. C., Domand, J. and Mani, J. C. (1978) 
Arch. Int. Physiol. Biochim. 86,846-847. 
Bomrafous, J. C., Domand, J. and Mani, J. C. (1979) 
BiochIm. Biophys. Acta in press. 
Zenser, T. V. (1975) Biochim. Biophys. Acta 404, 
202-213. 
Bonnafous, J. C., Dornand, J. and Mani, J. C. (1979) 
FEBS Lett. 39, 152-156. 
Salomon, Y., Londos, C. and Qodbell, M. (1974) 
Anal Biochem. 63, 388-399. 
Huang, M. and Drummond, G. L-(1978) Adv. Cyclic 
Nucl. Res. 9,341-353. 
Dornand, J., Bonnafous, J. C., Gavach, C. and Mani, 
J. C. (1979) Biochimie in press. 
Strom, T. B., LundIn, A. P. and Carpenter, C. B. 
(1977) Prog. CIln. Immunol. 3,115-153. 
Domand, J., Bonnafous, J. C. and Mani, I. C. (1978) 
Biochem. Biophys Res. Commun. 82,685-692. 
Domand, J., Bonnafous, J. C. and Mani, J. C. (1978) 
Eur. J. Biochem. 87,459-465. 
99 
